This group is for elite investors and traders that are dedicated to participating in an active community that wants to learn from each other, share their research, and work together to do deep analysis of securities. The moderator of this group taught securities analysis at UCLA and is dedicated to helping other investors improve their abilities.
In this private group, membership is restricted and regular contributions are required. Any member not contributing on a regular basis will be removed to make room for a new member.
In your application messsage, please share your background and what you can contribute to the group.
Company Overview and News
Baker Hughes, a GE company (BHGE - Free Report) reported second-quarter 2018 adjusted earnings of 10 cents per share, missing the Zacks Consensus Estimate of 13 cents owing to a drop in volumes of contractual activities and Subsea Services. This was partially negated by increased pressure pumping activities and contributions from Inspection Technologies.
BHI GEC GE CTLR BHGE MUR.WI GNE MUR MRO CLR
WASHINGTON (Reuters) - Baltimore filed a lawsuit on Friday against 26 oil and gas companies and entities, including BP Plc, Chevron Corp and Exxon Mobil Corp, for knowingly contributing to what the city called the catastrophic consequences of climate change.
RDS.B RDS.A CNX.WI HES XOM BP RDSB RDSA BP.A BP.B HES.PRA CEIX.WI BP CVX RYDBF MRO BPAQF RYDAF CEIX CNX
Chicago, IL –July 20, 2018 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include Marathon Oil Corp. (MRO - Free Report) ,Hess Corp. (HES - Free Report) , Anadarko Petroleum Corp. (APC - Free Report) , ConocoPhillips (COP - Free Report) and Whiting Petroleum Corp.
WFCNP APC HES MS.PRE WFC.PRL MS.PRF WFC.PRJ MS.PRG MS.PRA COP HES.PRA WFC.PRT WFC.PRR WFC.PRQ WFC.PRP WFC.PRO WFC.PRN WFC.PRY MS WFC.PRX WFC.PRW WFC.PRV WFC WFC.WS WLL MS.PRI MS.PRK MRO AEUA
Dublin and London - July 20, 2018 - Providence Resources P.l.c. (PVR LN, PRP ID), the Irish based Oil and Gas Exploration Company (the "Company"), today provides a technical update regarding Frontier Exploration Licence ("FEL") 3/04 located in the southern Porcupine Basin. FEL 3/04 is operated by Eni Ireland BV (36.913%) on behalf of its partners, Repsol Exploracion Irlanda SA (33.557%), Providence Resources P.
PVDRF PVRS LNSTY PVR MRO MIOI
The U.S. Energy Department's inventory release showed that crude stockpiles recorded a shock weekly build as domestic output hit 11 million barrels a day for the very first time. Despite the record production, U.S. benchmark crude futures gained 1% (or 68 cents) to $68.76 per barrel Wednesday. The positive price movement was supported by strong demand for refined product inventories.
COP HES.PRA APC WLL HES MRO AEUA
It’s earnings time again and investors are back to watching the quarterly releases closely. This time as well, we expect the Energy sector to contribute the maximum to earnings growth for the S&P 500.
COP APC CTLR MRO CLR AEUA EOG
Dublin and London - July 13, 2017 - Providence Resources P.l.c. (PVR LN, PRP ID), the Irish based Oil and Gas Exploration Company, provides a Licence Update on Frontier Exploration Licence ("FEL") 2/14.
CNE PVDRF CRNZF PVRS LNSTY PVR MRO MIOI CRNCY
On Jul 7, Penn Virginia Corporation (PVAC - Free Report) was upgraded to a Zacks Rank #1 (Strong Buy), implying that the stock will significantly outperform the broader U.S. equity market over the next one to three months.
PVAC CTLR ADI PVAYQ MUR.WI PVA MUR MRO CLR
It commonly happens in stock investing that investors miss the chance of buying winning stocks that they knew would stand out. Before they take the plunge, others get to know the hidden potential and enter into these stocks, pushing them out of reach.
Chicago, IL – July 11, 2018 – Today, Zacks Equity Research discusses the Industry: Oil & Gas – U.S. Integrated, including ConocoPhillips (COP - Free Report) , Marathon Oil Corp. (MRO - Free Report) , Occidental Petroleum Corp. (OXY - Free Report) and Hess Corp. (HES - Free Report) .
LPLA SCHW.PRBCL MOV HES SCHN IBKR MOVAA LSTR SFIX HOLI COP HES.PRA MRO PETS URBN OXY
On Jul 7, EOG Resources, Inc. (EOG - Free Report) has been upgraded to a Zacks Rank #1 (Strong Buy), implying that the stock will significantly outperform the broader U.S. equity market over the next one to three months.
CTLR MUR.WI MUR MRO CLR EOG
Transocean Ltd. (RIG - Free Report) announced the start of offering senior notes to potential investors. The notes, with aggregate pricing amount of $600 million, will carry an interest rate of 6.125% and are expected to mature by 2025.
CTLR MUR.WI MUR MRO CLR RIG SGAZF
2018-07-17 - Asif
History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...
2018-07-17 - Asif
Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...
2018-07-16 - Asif
General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...
Silicon Investor Message Boards
This table lists all message boards related to MRO / Marathon Oil Corp. on message board site Silicon Investor.
as of ET